Charles River Laboratories International Inc at Bank of America Merrill Lynch Health Care Conference Transcript
We'll go ahead and get started. Good morning. Welcome to the 2019 Bank of America Health Care Conference. Once again, my name is Juan Avendano, and I am an analyst in the life sciences tools and diagnostics team, which is led by Derik De Bruin. I focus on coverage of CROs and CDMOs, and I'm pleased to be joined on stage by Charles River. With us, we have David Smith, their CFO; and Birgit Girshick, who runs the Discovery and Safety Assessment segment as well as the Biologics Testing Solutions business. Welcome, and thank you once again for participating.
Questions & Answers
I guess, David, if you could start us off by summarizing the first quarter results that you just reported last week, that would be great. Thank you.
Okay. So in Q1, well, we're pleased with Q1,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |